Form 4: Hims & Hers Health Chief Legal Officer Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., reports the acquisition and disposal of Class A Common Stock and Restricted Stock Units.

Summary

  • On March 14, 2025, Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., acquired 43,210 shares of Class A Common Stock through the vesting of Restricted Stock Units (RSUs).
  • Also on March 14, 2025, 23,798 shares were withheld by the issuer to cover tax obligations related to the vesting of RSUs at a price of $33.14.
  • On March 18, 2025, Boughton sold 3,236 shares of Class A Common Stock at a price of $34.31.
  • These transactions were executed under a Rule 10b5-1 trading plan adopted on August 28, 2024.
  • Following these transactions, Boughton directly owns 173,521 shares of Class A Common Stock.
  • Boughton also holds various tranches of Restricted Stock Units (RSUs) with different vesting schedules, totaling 286,635 RSUs.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transactions are part of a pre-arranged trading plan and do not necessarily reflect a change in the officer's outlook on the company.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. It allows investors to monitor the actions of key personnel and their sentiment towards the company's stock.

Comparison to Industry Standards

  • Form 4 filings are standard practice for publicly traded companies and their insiders.
  • The Rule 10b5-1 trading plan is a common tool used by executives to avoid accusations of insider trading, similar to plans used by executives at companies like Amazon and Apple.
  • The vesting schedules of the RSUs are typical for employee compensation packages in the tech industry, comparable to vesting schedules at companies like Google and Meta.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders by slightly increasing the stock's trading volume.
  • The vesting of RSUs is part of the executive compensation plan, impacting the officer's overall remuneration.

Key Dates

DateDescription
June 15, 2022First possible vesting date for some RSUs.
June 15, 2023First possible vesting date for some RSUs.
June 15, 2024First possible vesting date for some RSUs.
August 28, 2024Date of adoption of Rule 10b5-1 trading plan.
March 14, 2025Date of RSU vesting and tax withholding.
March 18, 2025Date of stock sale.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.